AWB-25463-50805
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 750 / TX
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Registered in v-safe
-
2021-02-04
Dose 1 — Pfizer-BioNTech
- 2021-02-09
- 2021-02-25
-
2021-03-05
Dose 2 — Pfizer-BioNTech
-
2021-09-05
Survey response — 6 months, dose 2MedDRA: Rhinorrhoea, SARS-CoV-2 test negative — Feeling: GoodFree text: Runny nose, tested negative for COVIDMedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Pfizer-BioNTech | |
| 2 | 2021-03-05 | Pfizer-BioNTech |
Free text
Release 9 — 6 months, dose 2
Symptoms: Runny nose, tested negative for COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release